Brind.

Sanofi's GMMG-HD7 study was noted as being German-speaking in July 2025.

1 report, 1 independent Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sanofi's GMMG-HD7 study was noted as being German-speaking in July 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Sanofi

    company in Milan, Italy

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswirePress Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Sanofi’s Sarclisa approved in the EU for the treatment of transplant-elig